Skip to main content
Linlin Wang, MD, Pathology, San Francisco, CA

LinlinWangMD

Pathology San Francisco, CA

Hematopathology, Anatomic Pathology, Clinical Pathology

Physician

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wang's full profile

Already have an account?

  • Office

    505 Parnassus Ave
    San Francisco, CA 94143
    Phone+1 415-476-1000
    Fax+1 415-353-2765

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Pathology-Anatomic and Clinical, 2010 - 2014
  • Tongji Medical University
    Tongji Medical UniversityClass of 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2013 - 2025
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Pathology - Hematology

Publications & Presentations

PubMed

Abstracts/Posters

  • Development of a Pathway-Directed Drug Screen Platform for Cutaneous T Cell Lymphoma Using Patient-Derived Xenograft Models
    Linlin Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Nomenclature for Factors of the HLA System, Update July, August and September 2020
    Nomenclature for Factors of the HLA System, Update July, August and September 2020November 14th, 2020
  • Improved Clinical Outcomes of Preimplantation Genetic Testing for Aneuploidy Using MALBAC-NGS Compared with MDA-SNP Array
    Improved Clinical Outcomes of Preimplantation Genetic Testing for Aneuploidy Using MALBAC-NGS Compared with MDA-SNP ArrayJuly 3rd, 2020
  • The Kinetic Changes of Systemic Inflammatory Factors During Bevacizumab Treatment and Its Prognostic Role in Advanced Non-Small Cell Lung Cancer Patients
    The Kinetic Changes of Systemic Inflammatory Factors During Bevacizumab Treatment and Its Prognostic Role in Advanced Non-Small Cell Lung Cancer PatientsAugust 28th, 2019